Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Microbes and Infection|June 23, 2004
Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune responseScott J Hoffman, Federico R Laham, Fernando P Polack
Jornal De Pediatria|September 2, 2017
Viral bronchiolitis in young infants: new perspectives for management and treatmentMauricio T Caballero, Fernando P Polack, Renato T Stein
Clinical and Vaccine Immunology : CVI|December 18, 2015
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseasePatricio L Acosta, Mauricio T Caballero, Fernando P Polack
Indian Pediatrics|September 7, 2020
Clinical Manifestations and Outcomes of Respiratory Syncytial Virus Infection in Children Less Than Two Years in ColombiaJefferson Antonio Buendía, Fernando P Polack, Diana Guerrero Patiño
Frontiers in Pediatrics|May 16, 2022
TLR4 Gene Polymorphisms Interaction With Ascaris Infection in Severe RSV BronchiolitisJefferson Antonio Buendía, Erika Fernanda Lindarte, Fernando P Polack
BMC Public Health|November 10, 2020
Disability-adjusted life years for respiratory syncytial virus in children under 2 yearsJuana Patricia Sánchez Villamil, Fernando P Polack, Jefferson Antonio Buendía
Acta Medica Academica|November 15, 2020
RSV Lower Respiratory Tract Illness in Infants of Low- and Middle-income CountriesSofía L Laudanno, Clara I Sánchez Yanotti, Fernando P Polack
Human Vaccines & Immunotherapeutics|December 9, 2014
Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4Silvina Coviello, Vera Wimmenauer, Fernando P Polack, et al.
Translational Medicine Communications|September 28, 2020
Identifying pathophysiological bases of disease in COVID-19Carla J Goldin, Ramiro Vázquez, Fernando P Polack, et al.
The Journal of Infectious Diseases|September 23, 2016
Clinical Predictors of Critical Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus in Infants and Children: Data to Inform Case Definitions for Efficacy TrialsJessica E Atwell, Sarah Geoghegan, Ruth A Karron, et al.
Pageof 12